The first patient, a woman between 50 and 65 years old who was on ventilation for three to five weeks, occupied the room in September 2021, according to a case study published Aug. 3. The other patient was a woman older than 65 who was on ventilation for four weeks in January 2022.
Both were diagnosed with carbapenemase-producing, carbapenem-resistant Pseudomonas aeruginosa (CP-CRPA) infections from fifth and third, respectively, sputum specimens, which suggested a hospital-acquired infection. Between the two infected patients, 16 others stayed in the ICU room, and no other CP-CRPA specimens were found.
The second patient was discharged to a long-term care facility in late January. The first hospital contacted the next site about a precaution recommendation based on CP-CRPA detection, but this message was not given to the facility’s infection preventionist. No CP-CRPA infections were found at the second location.
The cluster was likely because of a contaminated sink, the CDC said. The recommended measures included a drain biofilm disinfectant and screening future patients who stay in that room, such as the next 10.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
